U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Mixed Cell Adenocarcinoma

MedGen UID:
83132
•Concept ID:
C0334324
•
Neoplastic Process
Synonym: Mixed cell adenocarcinoma
SNOMED CT: Mixed cell adenocarcinoma (38958001)

Definition

An adenocarcinoma characterized by the presence of a mixed malignant glandular cell population. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMixed Cell Adenocarcinoma

Professional guidelines

PubMed

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S
J Natl Compr Canc Netw 2023 Feb;21(2):181-209. doi: 10.6004/jnccn.2023.0006. PMID: 36791750
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.
Rolfo C, Mack P, Scagliotti GV, Aggarwal C, Arcila ME, Barlesi F, Bivona T, Diehn M, Dive C, Dziadziuszko R, Leighl N, Malapelle U, Mok T, Peled N, Raez LE, Sequist L, Sholl L, Swanton C, Abbosh C, Tan D, Wakelee H, Wistuba I, Bunn R, Freeman-Daily J, Wynes M, Belani C, Mitsudomi T, Gandara D
J Thorac Oncol 2021 Oct;16(10):1647-1662. Epub 2021 Jul 8 doi: 10.1016/j.jtho.2021.06.017. PMID: 34246791
Adjuvant treatment in renal cell carcinoma.
Dizman N, Adashek JJ, Hsu J, Bergerot PG, Bergerot CD, Pal SK
Clin Adv Hematol Oncol 2018 Aug;16(8):555-563. PMID: 30148828

Recent clinical studies

Etiology

Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H, Jiang S, Zhong P, Li W, Zhang S
J Ovarian Res 2021 Oct 21;14(1):137. doi: 10.1186/s13048-021-00896-9. PMID: 34674727Free PMC Article

Diagnosis

Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H, Jiang S, Zhong P, Li W, Zhang S
J Ovarian Res 2021 Oct 21;14(1):137. doi: 10.1186/s13048-021-00896-9. PMID: 34674727Free PMC Article

Prognosis

Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H, Jiang S, Zhong P, Li W, Zhang S
J Ovarian Res 2021 Oct 21;14(1):137. doi: 10.1186/s13048-021-00896-9. PMID: 34674727Free PMC Article

Clinical prediction guides

Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H, Jiang S, Zhong P, Li W, Zhang S
J Ovarian Res 2021 Oct 21;14(1):137. doi: 10.1186/s13048-021-00896-9. PMID: 34674727Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...